2Yr·

Has anyone read news about $IBRX (+9.92%) or knows what is going on? Almost 300% in one month.

11 Comments

2Yr

„NATIONAL MULTICENTER TRIAL OPENS TO STUDY IMMUNITYBIO'S TRI-AD5 CANCER
VACCINES PLUS N-803 TO PREVENT CANCER IN PEOPLE WITH LYNCH SYNDROME“ - Reuters

•

Yassin@RisingAktie

2Yr

Wanted to expand my position the other day when they were at just under € 2, but then they were already slowly shooting up again. Stupid timing until the money was on deposit :(

•

View all 3 further answers

Nico@itZNico

2Yr

"The increase in share prices is likely due to the positive momentum building around the company's lead pipeline candidate, N-803. The FDA is currently reviewing a regulatory submission for N-803 in combination with Bacillus Calmette-Guerin (BGC) for the treatment of patients with bladder cancer." Source: https://www.zacks.com/stock/news/2091284/immunitybio-ibrx-stock-jumps-432-will-it-continue-to-soar

•

Bimbam@Klambam

2Yr

@Clermit that did not run with as hoped. rebuy? 😂

•

MarsEquities@CircusClown

2Yr

@Klambam 😑das timing was of course pure comedy . Have been holding for ages and bought some more during and before the run and sold ~1/5 of the position at 5-6 again. Now again -40% all time with the rest . I personally buy rather between 1-1.5 after if it comes so far yet. Since there is no new date I suspect that it will take at least 3-6 months until the next decision, so it has for me no particular hurry to buy if it is not just again at the 52w low rumdümpelt. Of course only my personal opinion

•

MarsEquities@CircusClown

2Yr

What the others have already mentioned + general strength in biotech in recent weeks + insider buying in April by Soon-Shiong. IBRX was also sold off massively before that. YTD it is still "only" 22% up.

••

MarsEquities@CircusClown

2Yr

@Clermit shovel stocks is unfortunately no longer here but on his Twitter he regularly posts updates about IBRX.

•

Bimbam@Klambam

2Yr

@Clermit ah okay, thanks for the info 👍🏻

••